These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28596648)

  • 1. The Impact of Mean Platelet Volume (MPV) and JAK-2 Mutation on Thrombosis in Chronic Myeloproliferative Diseases.
    Ayer M; Menken İ; Yamak M; Ayer FA; Kırkızlar O; Burak Aktuğlu M
    Indian J Hematol Blood Transfus; 2017 Jun; 33(2):181-187. PubMed ID: 28596648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Analysis of Gene Mutation and Vascular Events in Patients with BCR/ABL Negative Myeloproliferative Neoplasms].
    Hu BD; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):813-818. PubMed ID: 35680810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mean platelet volume and immature platelet fraction as potential predictors of thrombotic complications in BCR/ABL-negative myeloproliferative neoplasms.
    Kissova J; Bulikova A; Ovesna P; Bourkova L; Penka M
    Int J Hematol; 2014 Nov; 100(5):429-36. PubMed ID: 25227185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
    Wehmeier A; Daum I; Jamin H; Schneider W
    Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean platelet volume and risk of thrombotic and bleeding complications in patients with Philadelphia chromosome negative myeloproliferative neoplasms.
    Krashin E; Cohen O; Pereg D; Lishner M; Leader A
    Blood Coagul Fibrinolysis; 2018 Apr; 29(3):288-293. PubMed ID: 29474204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean Platelet Volume in Pemphigus Vulgaris.
    Kridin K; Shihade W; Zelber-Sagi S
    Angiology; 2018 Apr; 69(4):303-307. PubMed ID: 28681645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Inflammation Parameters in Philadelphia Negative Chronic Myeloproliferative Neoplasia Patients.
    Hacibekiroglu T; Akinci S; Basturk A; inal B; Guney T; Bakanay SM; Dilek I
    Asian Pac J Cancer Prev; 2015; 16(13):5159-62. PubMed ID: 26225646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome?
    Korkmaz S; Uslu AU; Sahin S; Senel S; Sencan M
    Platelets; 2014; 25(5):343-7. PubMed ID: 23971949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of JAK2 V617F mutation on hemogram variation in patients with non-reactive elevated platelet counts.
    Zhou J; Ye Y; Zeng S; Zhou Y; Mao Z; Song X; Ying B; Lu X; Jiang H; Wang L
    PLoS One; 2013; 8(2):e57856. PubMed ID: 23469088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status.
    Vignoli A; Tessarolo S; Marchetti M; Gamba S; Piras F; Finazzi G; van der Meijden PE; Swieringa F; Ten Cate H; Heemskerk JW; Rambaldi A; Falanga A
    Thromb Res; 2016 Apr; 140 Suppl 1():S183. PubMed ID: 27161708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome.
    Martin-Garcia AC; Arachchillage DR; Kempny A; Alonso-Gonzalez R; Martin-Garcia A; Uebing A; Swan L; Wort SJ; Price LC; McCabe C; Sanchez PL; Dimopoulos K; Gatzoulis MA
    Heart; 2018 Jan; 104(1):45-50. PubMed ID: 28663364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study.
    Prajs I; Kuliczkowski K
    Adv Clin Exp Med; 2017; 26(1):115-121. PubMed ID: 28397442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myeloproliferative disorders.
    Spivak JL; Barosi G; Tognoni G; Barbui T; Finazzi G; Marchioli R; Marchetti M
    Hematology Am Soc Hematol Educ Program; 2003; ():200-24. PubMed ID: 14633783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean platelet volume and platelet distribution width levels in patients with mild psoriasis vulgaris with metabolic syndrome.
    Korkmaz S
    Postepy Dermatol Alergol; 2018 Aug; 35(4):367-371. PubMed ID: 30206448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis.
    Ataş H; Canpolat F; Eskioglu F
    Arch Iran Med; 2018 Jun; 21(6):234-239. PubMed ID: 29940741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.